Tim Wright, M.D.
Tim Wright, M.D.
General Partner
In a career spanning academic research, clinical medicine, big pharma, and biotech, Dr. Wright has guided the development of twenty breakthrough drugs now on the market, including 10 “blockbusters” that have each sold over $1 billion USD annually. He brings to Time BioVentures’ portfolio deep expertise in translational science and commercialization, as well as an understanding of the dynamics of the private and public biotech markets.
Dr. Wright began his career as a physician-scientist, completing his medical degree, rheumatology clinical fellowship, and post-docs in molecular biology and immunology at Johns Hopkins University. He subsequently served on the faculty at Hopkins, and then as a tenured Associate Professor and Division Chief at the University of Pittsburgh School of Medicine, where he ran an NIH-funded research laboratory.
Following a successful leap from academia to industry, Dr. Wright spent three years at Pfizer in Research and Exploratory Development. He then moved to Novartis Pharmaceuticals where he held roles of increasing responsibility, including Deputy Head of Translational Research, Global Head of Translational Medicine, Global Head of Translational Sciences, and finally, Global Head of Pharma Development.
In 2015, Dr. Wright moved to California and immersed himself in the fast-paced world of start-up biotech, first as Executive Vice President at CALIBR (affiliated with Scripps Research), and then as Chief R&D officer at Regulus Therapeutics. Dr. Wright serves as a scientific advisor to the Bill and Melinda Gates Foundation and the Leonard Schaeffer Center for Health Policy and Economics at USC. He has also held Board of Directors roles at Schrodinger and CureVac, two prominent public biotech companies.